Metropolitan Life Insurance Company (MetLife)’s Envista NVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,862
Closed -$1.3M 2540
2021
Q4
$1.3M Sell
28,862
-572
-2% -$23.5K 0.02% 792
2021
Q3
$1.23M Sell
29,434
-948
-3% -$40K 0.02% 810
2021
Q2
$1.31M Buy
30,382
+27,151
+840% +$1.18M 0.02% 799
2021
Q1
$132K Buy
3,231
+125
+4% +$4.76K ﹤0.01% 2293
2020
Q4
$105K Sell
3,106
-97
-3% -$2.81K ﹤0.01% 2339
2020
Q3
$79K Sell
3,203
-46
-1% -$1.06K ﹤0.01% 2351
2020
Q2
$68.5K Sell
3,249
-4,501
-58% -$84.4K ﹤0.01% 2449
2020
Q1
$116K Sell
7,750
-205
-3% -$5.25K ﹤0.01% 1945
2019
Q4
$236K Buy
+7,955
New +$226K ﹤0.01% 1799

Other funds holding NVST

Metropolitan Life Insurance Company (MetLife)'s NVST Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Envista (NVST) in Q1 2022, closing a stake of 28,862 shares — an estimated $1.3M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NVST in Q4 2019 and held it in 9 quarters. The position peaked at $1.31M in Q2 2021. 354 funds tracked by Wall St. Rank hold NVST as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Envista position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 28,862 Envista shares in Q1 2022, an estimated $1.3M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Envista in Q4 2019 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Envista position peaked at $1.31M in Q2 2021.
  • 354 funds tracked by Wall St. Rank held Envista as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.